Sabra Health Care REIT Q3 revenue rises to $190.0 million; net income falls
Sabra Health Care REIT reported third-quarter 2025 total revenues of $190.0 million, up from $178.0 million a year earlier, while diluted net income fell to $0.09 per share from $0.13. The company updated its 2025 earnings guidance and reported normalized FFO of $0.36 per diluted share, up from $0.35, which shows the mixed picture for shareholders.
Key points
- Total revenues were $190.0 million for the quarter ended September 30, 2025, versus $178.0 million a year earlier.
- Diluted net income was $0.09 per share versus $0.13 a year earlier; normalized FFO was $0.36 per share versus $0.35.
- 2025 guidance was updated to net income of $0.655 to $0.665 per diluted share and normalized FFO of $1.455 to $1.465 per diluted share.
- Board declared a quarterly dividend of $0.30 per share, payable November 28, 2025, to holders of record on November 17, 2025.
The filing
Written by AI on Nov 8, 2026, 1:05 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on November 05, 2025.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.